Semaglutide tablets vs injection: how the two forms compare

What the trial data says about each format

The clearest place to start is the numbers, because they're often quoted loosely. The injection's headline evidence comes from STEP 1, published in the New England Journal of Medicine, where adults on the 2.4mg weekly dose lost around 15% of their body weight over 68 weeks alongside diet and activity changes. That figure has anchored how people think about semaglutide for weight loss for several years.

The tablet's evidence is newer. OASIS 4, a phase 3 trial of 307 adults with obesity or overweight plus a weight-related condition, ran for 64 weeks against placebo. It reported around 13.6% average weight loss regardless of how closely people stuck to treatment, rising to about 17% among participants who stayed fully adherent, compared with roughly 2.4% on placebo. When you see a 17% figure quoted for the tablet, that's the fully-adherent group, not the plain average.

So the two forms land close together, with the injection's average a little higher in its own trial. These aren't head-to-head studies, though, so treat the gap as a rough guide rather than a precise ranking. What the data does tell you is that oral semaglutide is a genuinely effective option, not a watered-down alternative. If you want to sit with these figures a little longer, our page on whether the tablets are as effective as the injections goes deeper into the comparison.

Why the same drug comes as both a weekly pen and a daily tablet

Semaglutide is a GLP-1 receptor agonist. It works on gut-hormone signalling that governs appetite and fullness, and it slows how quickly your stomach empties. That mechanism is identical whether the molecule arrives by injection or by mouth, which is why both forms can produce meaningful weight loss.

The engineering challenge was getting a peptide like semaglutide to survive the stomach. Novo Nordisk solved it by co-formulating the tablet with an absorption enhancer called SNAC, which helps a portion of the dose cross the stomach lining before it's broken down. That's also why the tablet has to be taken so carefully, first thing on an empty stomach, which we cover further down.

The injection sidesteps digestion entirely by delivering semaglutide under the skin, where it's absorbed steadily over the week. That's the practical reason it's once-weekly rather than daily. The pen holds the dose in a pre-filled device you inject into the abdomen, thigh or upper arm, rotating sites each time.

The upshot is two routes to the same biological effect, each with trade-offs baked into how the drug reaches your bloodstream. The NHS explains the shared semaglutide mechanism and effects in plain terms if you want a neutral overview. For a side-by-side on the practical differences, our oral versus injection breakdown sits alongside this page.

The everyday routine each one asks of you

This is where the two formats diverge most, and it's often what decides things for people. The tablet is a daily commitment with a fussy routine. You take it first thing in the morning on an empty stomach with a small sip of plain water, up to about 120ml, then wait at least 30 minutes before any food, other drinks including coffee, or other tablets. Swallow it whole. Miss the empty-stomach window and absorption drops.

For some people that's genuinely easy: the tablet before the kettle goes on, then breakfast once you're back from the school run. For others, the 30-minute gap before that first coffee is a daily nuisance. It's worth being honest with yourself about your mornings.

The injection asks less of your day-to-day but more of you once a week. It's a single jab on the same day each week, no fasting required, taken whenever suits you. Many people find the weekly rhythm easier to keep than a daily one, though the trade-off is getting comfortable with an injection device. Our guide on how to take the semaglutide tablet correctly spells out the timing, and if you go the injection route you'll want to keep a sharps bin for safe disposal at home.

Neither routine is objectively better. The tablet suits people who dislike needles and don't mind a strict morning slot; the injection suits people who'd rather deal with treatment once and forget it for six days.

Storage and travel: where the tablet has an edge

Storage is a quietly important difference that only becomes obvious when you're packing a bag. The injection needs refrigeration, kept at 2 to 8°C, with only a limited room-temperature window once you take it out. Always check the exact window in the Patient Information Leaflet rather than guessing, because it varies by product and matters for stability.

That fridge requirement shapes travel. A weekend away means a cool bag; a longer trip means planning around where you'll store the pen, and air travel means keeping it cool in transit. It's manageable, but it's a logistics job.

The tablet doesn't need a fridge. It stores at room temperature, which makes it noticeably easier to travel with, throw in a wash bag, or keep by the bed. For frequent travellers or anyone who finds the fridge routine a hassle, that's a real point in the tablet's favour.

Set against that convenience is the tablet's daily discipline, so the storage win is partly offset by the routine we described above. There's no universally right answer here; it depends on how your life is arranged. The product SmPC on the eMC holds the exact storage detail for each form, and it's the source to trust over any general summary. If storage and portability are high on your list, our comparison of the pills versus the injection weighs those practical factors more fully.

Side by side: the key differences at a glance

Here's a factual summary of how the two formats compare on the points people ask about most. The weight-loss figures come from separate trials, not a head-to-head study, so read them as context rather than a direct contest.

Both are prescription-only and both start at a low dose that a prescriber titrates upward over time. The tablet climbs through 1.5mg, 4mg and 9mg to a 25mg maintenance dose; the injection climbs through 0.25mg up to 2.4mg, with a higher 7.2mg dose now available for eligible adults. For the fuller ladder on either, our page on the difference between the tablets and injections lays it out.

What to expect in terms of side effects

Because it's the same drug, the side-effect profile is broadly shared. The most common effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion and burping, plus tiredness and headaches for some. In OASIS 4, gastrointestinal side effects affected around 74% of people on the tablet versus 42% on placebo, and they were mostly mild to moderate and eased over time. They tend to be most noticeable when you start or step up a dose, then settle over days to a couple of weeks.

The injection carries the same GI-led profile, along with possible injection-site reactions the tablet obviously avoids. Slow, prescriber-led dose increases exist partly to keep these effects manageable, which is why neither form jumps straight to its top dose.

There are rarer but serious signals worth knowing. In January 2026 the MHRA issued a Drug Safety Update flagging acute pancreatitis as an uncommon but potentially serious effect across GLP-1 medicines: seek urgent help for severe, ongoing stomach pain that may spread to your back, with or without vomiting. That applies to both forms. If you suspect any side effect, you can report it through the MHRA Yellow Card scheme. Our prescribers talk you through what to watch for and support you across the first few weeks, seven days a week.

Eligibility, cost context and NHS access for each

The licensed eligibility is similar for both: adults with a BMI of 30 or above, or 27 and above with a weight-related condition such as high blood pressure, high cholesterol, prediabetes or sleep apnoea. Lower thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone never guarantees a prescription; a prescriber assesses your full picture before deciding either is suitable.

On the NHS, neither is a quick route. The injection is available only through specialist weight management services under strict NICE criteria, with long waits common, and the tablet isn't yet on the NHS at all, as a NICE appraisal would be needed first. Private treatment through a regulated online pharmacy is the alternative for people who don't qualify or don't want to wait. NHS England sets out the criteria for weight-management injections if you want the official position.

On cost, private weight-loss treatment is priced per month and varies by provider and dose. Any legitimate price should include the clinical assessment and prescription, not just the medicine. We're not the cheapest, and that's a deliberate choice: one clear price covers your consultation, prescription, next-working-day delivery and aftercare, with no subscription. Which form suits you is a clinical decision our prescribers make with you.

Related questions we've answered

• Is oral semaglutide as effective as the injection?
• Are semaglutide tablets better than injections?
• Is Wegovy a pill or an injection?
• Semaglutide tablets price
• How to take oral semaglutide